FL3 (flavagline)
FL3 (flavagline) is a synthetic flavagline derivative that has been extensively studied for its potential therapeutic applications in oncology and neurology. It is known for its potent anti-cancer and neuroprotective properties.
Chemistry[edit]
FL3 is a synthetic derivative of the natural product rocaglamide, which is a member of the flavagline class of compounds. Flavaglines are a group of compounds isolated from the plant genus Aglaia, known for their diverse biological activities.
Pharmacology[edit]
FL3 exhibits potent anti-cancer activity by inhibiting the synthesis of proteins necessary for tumor growth and survival. It acts by binding to the eukaryotic initiation factor 4A (eIF4A), an RNA helicase involved in the initiation of protein synthesis. By inhibiting eIF4A, FL3 disrupts the synthesis of proteins that are critical for cancer cell survival and proliferation.
In addition to its anti-cancer properties, FL3 has also been shown to have neuroprotective effects. It has been found to protect neurons from apoptosis (programmed cell death) induced by various stressors, suggesting potential applications in the treatment of neurodegenerative diseases.
Clinical Applications[edit]
The potent anti-cancer and neuroprotective properties of FL3 have led to its investigation as a potential therapeutic agent in a variety of clinical settings. Studies have shown that FL3 has potential therapeutic applications in the treatment of various types of cancer, including breast cancer, prostate cancer, and leukemia. In addition, its neuroprotective effects suggest potential applications in the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Safety and Toxicity[edit]
As with any potential therapeutic agent, the safety and toxicity of FL3 are important considerations. Preclinical studies have shown that FL3 has a favorable safety profile, with low toxicity observed in animal models. However, further studies are needed to fully assess the safety and potential side effects of FL3 in humans.
See Also[edit]
-
Flavagline FL3 structure
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
